Literature DB >> 5249197

Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis.

J T Connell.   

Abstract

Entities:  

Mesh：

Year:  1969        PMID： 5249197     DOI： 10.1016/0021-8707(69)90018-5

Source DB:  PubMed          Journal:  J Allergy        ISSN： 0021-8707


× No keyword cloud information.
  33 in total

Review 1.  Human nasal allergen provocation for determination of true allergic rhinitis: methods for clinicians.

Authors:  Ludmila I Litvyakova; James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

2.  Allergic rhinitis.

Authors:  M M Gibson; J H Day
Journal:  Can Fam Physician       Date:  1982-10       Impact factor: 3.275

3.  [The NTP in allergy research : open questions regarding nasal provocation tests using allergens].

Authors:  U Förster; A Sperl; L Klimek
Journal:  HNO       Date:  2013-10       Impact factor: 1.284

4.  Effect of the pollen season on nasal mast cells.

Authors:  M Viegas; E Gomez; J Brooks; D Gatland; R J Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

Review 5.  Nasal provocation.

Authors:  U Pipkorn
Journal:  Clin Rev Allergy       Date:  1988

6.  Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.

Authors:  U Pipkorn; D Proud; L M Lichtenstein; R P Schleimer; S P Peters; N F Adkinson; A Kagey-Sobotka; P S Norman; R M Naclerio
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

7.  Allergic rhinitis.

Authors:  O L Frick
Journal:  Calif Med       Date:  1972-12

Review 8.  Basophils in human disease.

Authors:  E B Mitchell; P W Askenase
Journal:  Clin Rev Allergy       Date:  1983-09

9.  The effect of platelet activating factor on nasal hypersensitivity.

Authors:  M Andersson; U Pipkorn
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 10.  Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.

Authors:  G W Canonica; E Compalati
Journal:  Clin Exp Immunol       Date:  2009-08-25       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.